Clinical Trials Directory

Trials / Unknown

UnknownNCT05915364

MAgna GraecIa Evaluation of Comorbidities in Patients With Heart Failure STUDY

MAgna GraecIa Evaluation of Comorbidities in Patients With Heart Failure STUDY (MAGIC-HF STUDY): Observational Study on Physiopathological, Diagnostic, Therapeutic, and Predictive Aspects of Heart Failure and Associated Comorbidities

Status
Unknown
Phase
Study type
Observational
Enrollment
500 (estimated)
Sponsor
University of Catanzaro · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The MAGIC-HF STUDY project (MAgna GraecIa evaluation of Comorbidities in patients with Heart Failure STUDY), is an observational prevalence and incidence study focusing on the role that risk factors, various comorbidities, and their treatment may have on CV and non-CV outcomes in patients with all forms of HF. It also aim to assess whether comorbidities and their treatment may be predictors of response to pharmacological and non-drug treatment of HF.

Detailed description

Adult subjects with all forms of HF (HFrEF, HFmrEf, HEpEF) with at least one comorbidity who are referred to the Heart Failure Outpatient Clinic of the AOU "Mater Domini" Geriatrics Unit in Catanzaro will be recruited. Initially, patients will be evaluated at baseline and followed-up for a minimum of six-month. All patients will be subjected to clinical, instrumental and laboratory examinations, including medical history data collection and complete anthropometric assessment . Plasma and serum samples will be collected at recruitment and at the six-months follow-up visit. Stool samples will also be obtained and stored at -80C for the omics studies.

Conditions

Timeline

Start date
2022-11-01
Primary completion
2024-06-01
Completion
2024-11-01
First posted
2023-06-23
Last updated
2023-06-23

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05915364. Inclusion in this directory is not an endorsement.